Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Short- and Long-term Health Adverse Outcomes Associated With Nutrition Disorders and Nutrition Related Conditions in Hospitalized Older People

3 mars 2022 uppdaterad av: Murielle Surquin, Brugmann University Hospital

Malnutrition is associated with health adverse outcomes such as higher risk of mobility disability, falls and, fractures and higher mortality. Malnutrition had been defined as "a state resulting from lack of intake or uptake of nutrition that leads to altered body composition (decreased fat free mass) and body cell mass leading to diminished physical and mental function and impaired clinical outcome from disease". In 2018, the European Society for Clinical Nutrition and Metabolism (ESPEN) revisited nutrition and nutrition-related conditions definitions in the ESPEN guidelines on definitions and terminology of clinical nutrition based on the findings of the last decades. Nutrition disorders and nutrition related conditions were divided in 5 categories: Malnutrition/undernutrition, sarcopenia and frailty, overweight and obesity, micronutrients abnormalities, and refeeding syndrome. The definition of malnutrition based on the Global Leadership Initiative on Malnutrition (GLIM) criteria is globally accepted by de scientific community since this was launched in 2019. The presence of at least one phenotypic (i.e., nonintentional weight loss, low body mass index or low muscle mass) and one etiologic criterion (i.e., reduced food intake or inflammation) were required to define malnutrition.

Malnutrition is a common pathological condition in older adults that can further influence and aggravate health-related muscle decline. Sarcopenia is known as a natural progressive decline in skeletal muscles occurring with age, with an age-related decline in muscle strength. According to the criteria published in 2019 by the European Working Group on Sarcopenia in Older People (EWGSOP2), this process is defined by the presence of low muscle strength and low muscle mass.

Patients in acute care are likely to present higher stay and risk of mortality. However, the mortality have rarely been applied in acute care, due to difficulties to administer Dual X-ray Absorptiometry (DXA), the gold standard method for muscle mass in acute care. Pragmatic approaches to assess nutrition and nutrition-related condition are urgently needed to provide better quality of care in clinical practice in geriatric medicine.

The primary objective of this study is to determine the impact of nutrition disorders and nutrition-related conditions at baseline (admission in hospitalization) on the all-causes mortality risk in hospitalized older people.

Secondarily, this study evaluates their impact on other health adverse outcomes: falls, fractures, rehospitalization, institutionalization, all-cause admission in intensive care, length of hospital stay, length of ventilation and USI stay.

Finally, the diagnostic performance indicators of the Mini Nutritional Assessment (MNA-SF) and the Geriatric Nutritional Risk Index (GNRI) for malnutrition assessment following the GLIM criteria were calculated.

Studieöversikt

Status

Rekrytering

Betingelser

Studietyp

Observationell

Inskrivning (Förväntat)

224

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

60 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Patients aged ≥60 and over admitted to the geriatric healthcare unit and/or the COVID-19 unit of the CHU Brugmann Hospital, between 01/01/2016 and 12/10/2021.

Beskrivning

Inclusion Criteria:

  • Patients aged ≥60 and over admitted to the geriatric healthcare unit and/or the COVID-19 unit of the CHU Brugmann Hospital, between 01/01/2016 and 12/10/2021.
  • Patients who had the assessment of nutrition disorders and/or nutrition related conditions available during their hospital admission.

Exclusion Criteria:

- No exclusion criteria based on demographical or medical data were applied.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Observationsmodeller: Kohort
  • Tidsperspektiv: Retrospektiv

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
All-cause mortality
Tidsram: From 2016 till 2021
Vital status (death/alive)
From 2016 till 2021

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Falls
Tidsram: From 2016 till 2021
Falls (yes/no)
From 2016 till 2021
Fractures of upper and lower limbs and/or hip and/or vertebrae
Tidsram: From 2016 till 2021
Fractures of upper and lower limbs and/or hip and/or vertebrae (yes/no)
From 2016 till 2021
Re-hospitalization
Tidsram: From 2016 till 2021
Unplanned readmission in hospital (yes/no)
From 2016 till 2021
Institutionalization
Tidsram: From 2016 till 2021
Institutionalization (yes/no)
From 2016 till 2021
All-cause admission in intensive care
Tidsram: From 2016 till 2021
All-cause admission in intensive care (yes/no)
From 2016 till 2021
Mechanical ventilation
Tidsram: From 2016 till 2021
Mechanical ventilation (yes/no)
From 2016 till 2021
Length of hospital stay time from admission to discharge
Tidsram: From 2016 till 2021
Length of hospital stay time from admission to discharge
From 2016 till 2021
Sensitivity
Tidsram: From 2016 till 2021
Diagnostic performance indicators: the ability of a screening test to identify malnourished patients according to the GLIM criteria.
From 2016 till 2021
Specificity
Tidsram: From 2016 till 2021
Diagnostic performance indicators: the ability of a screening test to identify non-malnourished patients according to the GLIM criteria.
From 2016 till 2021
Positive predictive value (PPV)
Tidsram: From 2016 till 2021
Positive predictive value is the proportion of positive screening test results that are true positives for the diagnosis of malnutrition according to GLIM criteria.
From 2016 till 2021
Negative predictive value (NPV)
Tidsram: From 2016 till 2021
Negative predictive value (NPV) is the proportion of negative screening test results that are true negative for the diagnosis of malnutrition according to the GLIM criteria.
From 2016 till 2021
Area under the ROC curve (AUC)
Tidsram: From 2016 till 2021
A measure of the precision of a quantitative diagnostic test, which gives equal weight to sensitivity and specificity.
From 2016 till 2021

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Marie Claessens, CHU Brugmann

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

12 oktober 2021

Primärt slutförande (Förväntat)

31 december 2022

Avslutad studie (Förväntat)

31 december 2022

Studieregistreringsdatum

Först inskickad

3 mars 2022

Först inskickad som uppfyllde QC-kriterierna

3 mars 2022

Första postat (Faktisk)

11 mars 2022

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

11 mars 2022

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

3 mars 2022

Senast verifierad

1 mars 2022

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • CHUB-Nutrition disorders

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

Nej

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera